Texas joins 5 states suing opioid maker Purdue Pharma

Adjust Comment Print

Attorney General Slatery said, "Our office has conducted an extensive investigation into Purdue's highly aggressive marketing practices and other unlawful conduct".

"Purdue felt fit to destroy lives for financial gain", Paxton said.

- Six more USA states on Tuesday announced lawsuits against OxyContin maker Purdue Pharma LP, accusing the company of fueling a national opioid epidemic by deceptively marketing its prescription painkillers to generate billions of dollars in sales. Opioid-related hospitalizations have increased from 2010 to 2016 by 136 percent in emergency room encounters and 84 percent in inpatient admissions.

Among about two dozen community members, anti-drug activists and counselors in attendance at today's announcement, which took place at the Grant Sawyer Building, 555 E. Washington Ave., Edward and Cindy Yenick, attending from Reno, said their son, Michael, was died as a result of addiction to opioids prescribed after he suffered knee and back injuries while playing football in 2001 for UNR. Of the top 25 cities for opioid abuse, four are in Texas - Texarkana, Amarillo, Odessa and Longview.

Similar complaints were being filed by officials in Nevada, Florida, Tennessee, Texas and North Dakota. The consumer protection statute forbids companies from misrepresenting themselves or their products to Texans. Nevada and five other states filed lawsuits accusing the pharmaceutical company of using deceptive marketing to boost drugs sales that fueled opioid overdose deaths.

"There's nothing like talking to a mom who's lost her son from an overdose", Paxton said.

"Needless to say, our country is feeling a lot of pain in the hands of pain pills", Paxton said.

In September, Paxton announced he was joining a 41-state investigation of companies that manufacture or sell opioids. Multiple states are suing Purdue Pharma.

- Falsely representing that Purdue's abuse-deterrent formulation of OxyContin reduces the risks of OxyContin, including the risk of addiction.

Sales of Purdue Pharma opioids are worth billions of dollars every year nationwide.